Search for the latest oncology news by tumour type
‘Christmas berry’ plant compound could fight Uveal melanoma
Doctors diagnose about 2000 adults with uveal melanoma, a cancer of the eye, every year.…
Browsing: Tumour Stream
Mayo Clinic discovers biological markers that could guide treatment for prostate cancer
Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbour…
An errant editing enzyme promotes tumour suppressor loss and leukaemia propagation
Writing in the journal Cancer Cell, researchers at University of California San Diego School of Medicine…
Experimental treatment shows promise against triple-negative breast cancer
By simultaneously tackling two mechanisms for cancer’s growth, an experimental therapy reduced the spread of…
Study reveals how solid stress from brain tumours causes neuronal loss, neurologic dysfunction
A Massachusetts General Hospital (MGH)-led research team has demonstrated, for the first time, how solid…
Hopkins researchers ID new biomarker for colorectal cancers
Johns Hopkins researchers have identified a protein involved in cell proliferation and the development of…
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk…
Researchers develop personalised medicine tool for inherited colorectal cancer syndrome
An international team of researchers led by Huntsman Cancer Institute (HCI) at the University of…
SABCS 2018: Adjuvant capecitabine did not significantly improve outcomes for patients with early-stage triple-negative breast cancer
Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they…
SABCS 2018: Adjuvant chemotherapy might not add benefit in breast cancer patients who have excellent response to neoadjuvant chemotherapy
Pathological complete response (pCR) after neoadjuvant (presurgery) chemotherapy was associated with significantly lower recurrence risk…